BRIEF — Transthera Sciences (Nanjing) Says Yochanra (Tinengotinib) Included In CSCO Guidelines
Sept 18 (Reuters) — TransThera Sciences (Nanjing): Yochanra (Tinengotinib) Included In Csco Guidelines For Advanced Biliary Tract Cancers Further company coverage: 2617.HK (Reuters.Briefs@thomsonreuters.com;)